Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they ...
BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Handheld imaging device combines advanced optics with deep learning to enable early detection of epithelial cancers ...
Researchers at Mayo Clinic have developed an artificial intelligence (AI) system that could transform how pancreatic cancer ...
Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the ...
Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer derived from screening ...
Medicine has always operated as an “evidence based” field, meaning that it generally pursues experimentation to gather ...
The pigeons in the study even started recognizing other health problems they weren't trained on.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...